Evotec stock rebounds 3.07% as traders weigh earnings pressure
Published on 08/27/2026 at 07:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Evotec stock (ISIN DE0005664809) climbed 3.07% to $3.3540 on August 26, 2026, and the move came with an intraday market cap of EUR 595.988 million. The latest reported quarter on record in the available data was Q1 FY26, with revenue of $156.64 million and earnings of minus $121.94 million.
Price action stays tight
Shares settled at $3.3540 at the close on August 26, 2026, after opening the session at $3.25 on Xetra and moving to a 52-week low zone that has kept valuation pressure in view. The stock also traded at $3.38 on one market snapshot later the same day, showing how quickly the tape shifted across venues.
That gap matters for investors because the market is still digesting the companys latest reported quarterly losses while a modest rebound pushes the share price away from the recent floor.
Latest reported numbers
In Q1 FY26, Evotec reported revenue of $156.64 million and earnings of minus $121.94 million, according to the latest snapshot in the result set. The comparison is clear: revenue was still far below profitability, and the earnings figure remained deeply negative.
The same snapshot also shows current market attention remains centered on the relationship between sales scale and losses rather than on a pure valuation rerating. A 3.07% daily gain does not change that arithmetic, but it does show traders are still willing to buy the dip.
Product angle
Evotec builds drug-discovery and development services for pharmaceutical partners, which makes its pipeline partnerships and lab execution more important than a single consumer product line. For investors, that means quarterly revenue and earnings delivery carry more weight than a one-off headline.
Stock level watch
Evotec stock traded at $3.3540 on August 26, 2026, with the same-day market cap listed at EUR 595.988 million and a close-up move of 3.07% on the session. The share price now sits well below levels that would suggest a cleaner earnings story.
Evotec stock data
Company: Evotec SE
ISIN: DE0005664809
Ticker: EVT.DE
Exchange: Xetra
Price (as of August 26, 2026, 5:35 p.m. ET): $3.3540 USD
Market cap: EUR 595.988 million (as of August 26, 2026)
Sector / Industry: Healthcare / Drug Manufacturers - Specialty & Generic
Index membership: TecDAX
